Glucose homeostasis in Prader-Willi syndrome and potential implications ofgrowth hormone therapy

Authors
Citation
Wb. Zipf, Glucose homeostasis in Prader-Willi syndrome and potential implications ofgrowth hormone therapy, ACT PAEDIAT, 88, 1999, pp. 115-117
Citations number
9
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
ACTA PAEDIATRICA
ISSN journal
08035253 → ACNP
Volume
88
Year of publication
1999
Supplement
433
Pages
115 - 117
Database
ISI
SICI code
0803-5253(199912)88:<115:GHIPSA>2.0.ZU;2-D
Abstract
Diabetes mellitus is becoming a more frequently recognized complication of Prader-Willi syndrome. It has been reported that as many as 7-20% of indivi duals with Prader-Willi syndrome may develop this complication. Diabetes me llitus adds to the complexity of an already complex treatment program, caus es many serious complications that greatly affect the quality of life of th ese individuals, and can lead to serious morbidity and mortality. Recent st udies suggest that growth hormone (GH) might offer significant advantages t o individuals with Prader-Willi syndrome. However, as a known diabetogenic agent, GH might also increase the propensity to develop diabetes mellitus. For this reason, the characteristics of the diabetes mellitus that develops in individuals with Prader-Willi syndrome must be studied and fully unders tood. The initial assumption has been that the diabetes mellitus associated with this syndrome is identical to that seen in obese individuals without Prader-Willi syndrome, in whom genetic factors and obesity lead to insulin resistance. Severe insulin resistance in turn leads to pancreatic failure a nd hence the symptom complex of type 2 diabetes mellitus. To determine if t his same pattern is present in patients with Prader-Willi syndrome, we eval uated both obese children and adults with the syndrome. These patients were compared with obese individuals without Prader-Willi syndrome matched for age, gender and weight and who had not yet developed diabetes but had equal ly longstanding obesity. We compared the glucose and insulin responses of t hese two groups, using both oral and intravenous glucose challenges. The re sults demonstrated that individuals with Prader-Willi syndrome do not show the predicted insulin resistance that is seen in obese children without the syndrome. In fact, the individuals with Prader-Willi syndrome showed norma l or increased insulin sensitivity. These data do not support the hypothesi s that the high incidence of diabetes mellitus in patients with Prader-Will i syndrome is simply the result of obesity and therefore suggest a differen t aetiology.